Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial.

Trial Profile

Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial.

Not stated
Phase of Trial: Phase II

Latest Information Update: 04 Jun 2013

At a glance

  • Drugs Gemcitabine (Primary) ; Cisplatin
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Updated results for 120 patients presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 16 Mar 2011 New trial record
    • 19 Feb 2011 Results presented at the 2011 Genitourinary Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top